Evidence map›Paper›PMID 30186541›Full record

ReviewOxidative medicine and cellular longevity2018

Ferulated Arabinoxylans and Their Gels: Functional Properties and Potential Application as Antioxidant and Anticancer Agent.

Mayra Alejandra Mendez-Encinas, Elizabeth Carvajal-Millan, Agustín Rascon-Chu, Humberto Francisco Astiazaran-Garcia, Dora Edith Valencia-Rivera

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 108 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mayra Alejandra Mendez-EncinasBiopolymers, Research Center for Food and Development, CIAD, A.C. Carretera a La Victoria Km. 0.6, 83304 Hermosillo, SON, Mexico.
Elizabeth Carvajal-MillanBiopolymers, Research Center for Food and Development, CIAD, A.C. Carretera a La Victoria Km. 0.6, 83304 Hermosillo, SON, Mexico.ORCID 0000-0003-4390-7457
Agustín Rascon-ChuBiotechnology, Research Center for Food and Development, CIAD, A.C. Carretera a La Victoria Km. 0.6, 83304 Hermosillo, SON, Mexico.
Humberto Francisco Astiazaran-GarciaNutrition, Research Center for Food and Development, CIAD, A.C. Carretera a La Victoria Km. 0.6, 83304 Hermosillo, SON, Mexico.
Dora Edith Valencia-RiveraDepartment of Chemical Biological and Agropecuary Sciences, University of Sonora, Avenida Universidad e Irigoyen, 83621 Caborca, SON, Mexico.
Centro de Investigación en Alimentación y Desarrollo · MXUniversidad de Sonora · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last years, biomedical research has focused its efforts in the development of new oral delivery systems for the treatment of different diseases. Ferulated arabinoxylans are polysaccharides from cereals that have been gaining attention in the pharmaceutical field due to their prebiotic, antioxidant, and anticancer properties. The antioxidant and anticancer properties of these polysaccharides make them attractive compounds for the treatment of cancer, particularly colon cancer. In addition, ferulated arabinoxylans can form covalent gels through the cross-linking of their ferulic acids. Due to their particular characteristics, ferulated arabinoxylan gels represent an excellent alternative as colon-targeted drug delivery systems. The aim of the present work is to review the physicochemical and functional properties of ferulated arabinoxylans and their gels and to present the future perspectives for potential application as antioxidant and anticancer agents.

Indexed as

Antineoplastic AgentsAntioxidantsGelsXylansAntineoplastic AgentsAntioxidantsarabinoxylanGelsXylans

Identifiers

PMID30186541
PMCPMC6116397
OpenAlexW2886596517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.